Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-25 @ 8:50 PM
NCT ID: NCT01541969
Term: Tinnitus worsened
Organ System: Ear and labyrinth disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: None
Notes: In Acoustic CR Neuromodulation group AE reported by 2 participants during 12 week RCT phase, and 2 participants in the LTE phase (weeks 13 to 36). In the Tinnitus Masking group AE reported by 3 participants in the LTE phase (after crossover).
Study: NCT01541969
Study Brief: Evaluation of the CR Neuromodulation Treatment for Tinnitus
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 4 4 50 View
EG001 3 3 50 View